Informações:
Falhas:
ID
25172
Descrição
Tysabri Observational Program; ODM derived from: https://clinicaltrials.gov/show/NCT00493298
Link
https://clinicaltrials.gov/show/NCT00493298
Palavras-chave
Versões (1)
- 28/08/2017 28/08/2017 -
Transferido a
28 de agosto de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Relapsing-Remitting Multiple Sclerosis NCT00493298
Eligibility Relapsing-Remitting Multiple Sclerosis NCT00493298
- StudyEvent: Eligibility
Similar models
Eligibility Relapsing-Remitting Multiple Sclerosis NCT00493298
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Multiple Sclerosis, Relapsing-Remitting
Item
documented diagnosis of relapsing remitting multiple sclerosis
boolean
C0751967 (UMLS CUI [1])
Tysabri
Item
the decision to treat with tysabri must precede enrollment
boolean
C1529600 (UMLS CUI [1])
Tysabri Use of Firstly | Tysabri Infusion Quantity
Item
patient must be a new tysabri user, and must not have had more than 3 tysabri infusions prior to enrollment
boolean
C1529600 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
C1279901 (UMLS CUI [1,3])
C1529600 (UMLS CUI [2,1])
C0574032 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
C1524063 (UMLS CUI [1,2])
C1279901 (UMLS CUI [1,3])
C1529600 (UMLS CUI [2,1])
C0574032 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
Relapse Quantity | Indication Tysabri
Item
must have had at least one relapse in the previous year, and must satisfy locally approved therapeutic indications for tysabri
boolean
C0035020 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C3146298 (UMLS CUI [2,1])
C1529600 (UMLS CUI [2,2])
C1265611 (UMLS CUI [1,2])
C3146298 (UMLS CUI [2,1])
C1529600 (UMLS CUI [2,2])
Exclusion Criteria Main
Item
key exclusion criteria:
boolean
C0680251 (UMLS CUI [1,1])
C1542147 (UMLS CUI [1,2])
C1542147 (UMLS CUI [1,2])
Leukoencephalopathy, Progressive Multifocal | Opportunistic Infections | Opportunistic Infections Risk Increased
Item
history of progressive multifocal leukoencephalopathy or other opportunistic infections, or an increased risk of opportunistic infections
boolean
C0023524 (UMLS CUI [1])
C0029118 (UMLS CUI [2])
C0029118 (UMLS CUI [3,1])
C0035647 (UMLS CUI [3,2])
C0205217 (UMLS CUI [3,3])
C0029118 (UMLS CUI [2])
C0029118 (UMLS CUI [3,1])
C0035647 (UMLS CUI [3,2])
C0205217 (UMLS CUI [3,3])
Natalizumab Ab Positive
Item
history of positive anti-natalizumab antibodies
boolean
C1977362 (UMLS CUI [1,1])
C1514241 (UMLS CUI [1,2])
C1514241 (UMLS CUI [1,2])
Immunomodulation | Therapeutic immunosuppression | Tysabri
Item
concomitant immunomodulatory or immunosuppressive therapy during therapy with tysabri
boolean
C1963758 (UMLS CUI [1])
C0021079 (UMLS CUI [2])
C1529600 (UMLS CUI [3])
C0021079 (UMLS CUI [2])
C1529600 (UMLS CUI [3])
Patient Immunocompromised
Item
patient immunocompromised at the time of enrollment
boolean
C0030705 (UMLS CUI [1,1])
C0085393 (UMLS CUI [1,2])
C0085393 (UMLS CUI [1,2])
Malignant Neoplasms
Item
known active malignancy
boolean
C0006826 (UMLS CUI [1])
Breast Feeding | Pregnancy | Pregnancy, Planned | Gender Contraceptive methods | Exception Female Sterilization
Item
women must not be breast feeding or pregnant, or planning to become pregnant (must use birth control unless surgically sterile)
boolean
C0006147 (UMLS CUI [1])
C0032961 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
C0079399 (UMLS CUI [4,1])
C0700589 (UMLS CUI [4,2])
C1705847 (UMLS CUI [5,1])
C0015787 (UMLS CUI [5,2])
C0032961 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
C0079399 (UMLS CUI [4,1])
C0700589 (UMLS CUI [4,2])
C1705847 (UMLS CUI [5,1])
C0015787 (UMLS CUI [5,2])
Clinical Trial Eligibility Criteria Study Protocol
Item
note: other protocol defined inclusion/exclusion criteria may apply.
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,2])